Jonathan Couchman, 10% Owner at ENZON PHARMACEUTICALS, INC. (ENZN), bought 998,402 shares at $0.26 ($259K) on 2018-04-13, disclosed to the SEC on 2019-01-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 4,700 | $1K | 0.5% |
| 2 | $0.26 | 185,700 | $48K | 18.7% |
| 3 | $0.26 | 3,000 | $780 | 0.3% |
| 4 | $0.26 | 33,500 | $9K | 3.4% |
| 5 | $0.26 | 55,000 | $14K | 5.5% |
| 6 | $0.26 | 4,000 |
| $1K |
| 0.4% |
| 7 | $0.26 | 20,200 | $5K | 2.0% |
| 8 | $0.26 | 50,000 | $13K | 5.0% |
| 9 | $0.26 | 5,500 | $1K | 0.6% |
| 10 | $0.26 | 1,000 | $260 | 0.1% |
| 11 | $0.26 | 2,000 | $520 | 0.2% |
| 12 | $0.26 | 68,195 | $18K | 6.9% |
| 13 | $0.26 | 500 | $130 | 0.1% |
| 14 | $0.26 | 1,120 | $291 | 0.1% |
| 15 | $0.26 | 32,345 | $8K | 3.3% |
| 16 | $0.26 | 1,300 | $338 | 0.1% |
| 17 | $0.26 | 600 | $156 | 0.1% |
| 18 | $0.26 | 20,000 | $5K | 2.0% |
| 19 | $0.26 | 21,975 | $6K | 2.2% |
| 20 | $0.26 | 2,800 | $728 | 0.3% |
| 21 | $0.26 | 635 | $165 | 0.1% |
| 22 | $0.26 | 355 | $92 | 0.0% |
| 23 | $0.26 | 11,368 | $3K | 1.1% |
| 24 | $0.26 | 26,655 | $7K | 2.7% |
| 25 | $0.26 | 112 | $29 | 0.0% |
| 26 | $0.26 | 8,255 | $2K | 0.8% |
| 27 | $0.26 | 40,316 | $10K | 4.1% |
| 28 | $0.26 | 9,500 | $2K | 1.0% |
| 29 | $0.26 | 384,100 | $99K | 38.2% |
| 30 | $0.26 | 3,671 | $936 | 0.4% |
| Total | $0.26 avg | 998,402 | $259K | 100% |
| Filing → |
| ENZN | BUY | 2019-01-09 | $379K | — | Filing → |